US Broker Ratings

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Promising 4.6% Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a pivotal player in the healthcare sector, specializes in providing comprehensive pharmacy services to long-term care facilities (LTCFs) across the United States. With a..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 13.4% Potential Upside with Expert Consensus

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, stands out in the medical devices industry with a robust market presence and a compelling growth narrative. Headquartered in..

HUTCHMED (China) Limited (HCM) Investor Outlook: Analyzing the 42.99% Potential Upside

HUTCHMED (China) Limited (HCM) emerges as a compelling player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. Headquartered in Hong Kong, this company is..

PACS Group, Inc. (PACS) Stock Analysis: A 16.9% Potential Upside in Healthcare Facilities

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, particularly in the medical care facilities industry, presents an intriguing case for investors seeking exposure to the robust U.S...

BioCryst Pharmaceuticals (BCRX): Investor Outlook Reveals Stunning 220% Potential Upside

For investors seeking opportunities in the healthcare sector, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) presents a compelling case with its robust pipeline and significant upside potential. With a market capitalization of..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A 29.76% Upside Potential Awaits Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is capturing investor attention with its robust growth prospects and a significant potential upside. With a market..

Ascentage Pharma Group (AAPG) Stock Analysis: Biotech Giant with 91.92% Potential Upside

Ascentage Pharma Group International (AAPG) has been capturing the attention of investors with its promising pipeline and robust potential upside of 91.92%. Operating in the biotechnology sector of the healthcare..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential 100% Upside Amidst Challenging Financials

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) operates at the cutting edge of biotechnology, merging biology and chemistry with advanced data science and engineering to revolutionize drug discovery. Based in Salt Lake..

Centessa Pharmaceuticals plc (CNTA) Investor Outlook: Analyzing a 60% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) stands as a compelling opportunity within the biotechnology sector, appealing to investors with its strong potential upside of 60.32%. Despite its relatively recent inception in..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential

Investors with an eye on the biotechnology sector may find Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) an intriguing prospect. With a robust market capitalization of $6.17 billion and a focus on..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 52.95% Potential Upside in the Biotech Space

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, stands out with a robust market cap of $1.82 billion. As a commercial-stage biopharmaceutical company, Vericel is at the..

Belite Bio, Inc (BLTE) Stock Report: Analyst Ratings Signal Strong Buy with 9.62% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE), a dynamic player in the biotechnology sector, has captured the attention of investors with its promising clinical-stage drug development efforts focused on retinal degenerative eye..

Certara, Inc. (CERT) Stock Analysis: Exploring an 86.93% Potential Upside in Healthcare Tech

For investors with an eye on the healthcare technology sector, Certara, Inc. (NASDAQ: CERT) presents an intriguing proposition. With a current market cap of $1.05 billion, this U.S.-based company is..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: 42% Upside Potential Ignites Investor Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of investors with its promising growth prospects and a compelling potential upside. As a prominent player in the healthcare sector, specifically..

Apellis Pharmaceuticals (APLS) Stock Analysis: 56% Potential Upside Beckons Investors

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a noteworthy player in the biotechnology sector, with a focus on developing and commercializing innovative therapeutic compounds. Headquartered in Waltham, Massachusetts, Apellis operates within..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenging Waters in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector specializing in active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives, has recently caught the attention of investors. Based in..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Evaluating a 219.73% Potential Upside in Biotech Innovation

Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotech sector, thanks to its robust pipeline of innovative drug candidates and an impressive potential upside of 219.73%, as..

Investor Outlook: Galapagos NV (GLPG) Faces Challenges Amidst Potential Downside

Galapagos NV (NASDAQ: GLPG), a biotechnology firm hailing from Belgium, is capturing investor attention not only for its innovative medical advancements but also for the financial challenges it currently faces...

PROCEPT BioRobotics (PRCT) Stock Analysis: A 83% Upside Potential Awaits in Revolutionary Medical Devices

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative approach to urologic surgery. Specializing in surgical robotics, this San Jose-based company is gaining attention..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Revenue Growth Soars as Analysts Eye 24.65% Upside

Alignment Healthcare, Inc. (ALHC), a key player in the healthcare plans industry, has been capturing investor attention with its remarkable revenue growth and a promising potential upside. Based in Orange,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds